RhebL1, also known as Ras homolog enriched in brain-like 1, is part of the Ras superfamily of small GTPases. Like other members of this superfamily, RhebL1 functions as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state. These conformational states allow RhebL1 to interact with various effector proteins, thereby influencing a range of cellular processes. The precise roles and pathways associated with RhebL1 are still subjects of active research, but its association with the Ras superfamily suggests involvement in signal transduction pathways, cellular growth, and cytoskeletal dynamics. The ability of RhebL1 to modulate these pathways underscores its significance in maintaining cellular homeostasis and facilitating responses to external and internal cues.
Activators of RhebL1 are molecules or compounds that enhance the activity or expression of RhebL1. These activators might function by promoting the transcription of the RhebL1 gene, by stabilizing the RhebL1 protein structure, or by promoting its transition to the active GTP-bound state. The presence of RhebL1 activators can influence the dynamics of the pathways in which RhebL1 is involved, modulating the cellular processes regulated by this GTPase. Exploring the domain of RhebL1 activators offers a window into the multifaceted world of small GTPase regulation and the intricate molecular networks that shape cellular responses. As our understanding of cellular signaling and GTPase function deepens, the role of RhebL1 and its activators emerges as an intriguing narrative, highlighting the complex molecular interplay that defines cellular behavior and fate.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which could indirectly influence RhebL1's activity or expression given the interplay between mTOR and Rheb proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Known to activate the mTOR pathway, might have an indirect effect on RhebL1 expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AMPK activator, which could potentially modulate mTOR signaling and indirectly influence RhebL1. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Activates AMPK and could indirectly modulate mTOR signaling, potentially influencing RhebL1. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $32.00 $128.00 | 3 | |
PI3K/mTOR inhibitor that might influence RhebL1 expression indirectly via modulation of the mTOR pathway. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | $173.00 $695.00 | 42 | |
Inhibits AKT signaling, potentially affecting mTOR signaling and indirectly RhebL1. | ||||||